T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Mohawk Industries
MHK
$9.27B
| $11.8M | ﹤0.01% |
154,663
+9,259
| +6% | +$1.1M |
|
1202
Middleby
MIDD
$5.38B
| $11.7M | ﹤0.01% |
205,367
-43,977
| -18% | -$4.31M |
|
1203
Pultegroup
PHM
$24.6B
| $11.7M | ﹤0.01% |
522,770
+33,871
| +7% | +$1.31M |
|
1204
Plains GP Holdings
PAGP
$4.98B
| $11.6M | ﹤0.01% |
2,075,845
+671,764
| +48% | +$9.45M |
|
1205
iShares National Muni Bond ETF
MUB
$45.9B
| $11.5M | ﹤0.01% |
101,905
-146,641
| -59% | -$16.7M |
|
1206
Regenxbio
RGNX
$720M
| $11.4M | ﹤0.01% |
353,144
-76,221
| -18% | -$3.18M |
|
|
DISCK
1207
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $11.4M | ﹤0.01% |
651,856
+2,183
| +0.3% | +$56.3K |
|
1208
Albemarle
ALB
$15.4B
| $11.4M | ﹤0.01% |
202,812
+17,080
| +9% | +$1.31M |
|
1209
Velocity Financial
VEL
$711M
| $11.4M | ﹤0.01% |
+1,515,212
| New | +$17.7M |
|
1210
New Fortress Energy
NFE
$93M
| $11.4M | ﹤0.01% |
1,164,908
-20,845
| -2% | -$292K |
|
1211
Garrett Motion
GTX
$5.47B
| $11.4M | ﹤0.01% |
3,987,012
+541,590
| +16% | +$3.94M |
|
1212
RingCentral
RNG
$5.25B
| $11.4M | ﹤0.01% |
53,787
+25,155
| +88% | +$5.18M |
|
|
AIV
1213
Aimco
AIV
$379M
| $11.3M | ﹤0.01% |
2,413,197
+186,889
| +8% | +$1.2M |
|
|
CDK
1214
DELISTED
CDK Global, Inc.
CDK
| $11.3M | ﹤0.01% |
342,881
-677
| -0.2% | -$32.3K |
|
1215
FS Bancorp
FSBW
$325M
| $11M | ﹤0.01% |
611,038
+4,340
| +0.7% | +$109K |
|
1216
Criteo S.A. Ordinary Shares
CRTO
$872M
| $11M | ﹤0.01% |
1,380,934
+88,426
| +7% | +$1.13M |
|
1217
Assembly Biosciences
ASMB
$536M
| $10.9M | ﹤0.01% |
61,426
-12,548
| -17% | -$2.69M |
|
1218
Whirlpool
WHR
$2.79B
| $10.9M | ﹤0.01% |
127,366
+10,702
| +9% | +$1.41M |
|
1219
Newell Brands
NWL
$2.62B
| $10.7M | ﹤0.01% |
804,728
+61,035
| +8% | +$1.05M |
|
1220
Lincoln National
LNC
$8.67B
| $10.6M | ﹤0.01% |
404,525
+31,375
| +8% | +$1.49M |
|
|
RAVN
1221
DELISTED
Raven Industries Inc
RAVN
| $10.5M | ﹤0.01% |
495,010
-157,005
| -24% | -$4.6M |
|
1222
Wave Life Sciences
WVE
$1.02B
| $10.2M | ﹤0.01% |
1,087,536
-38,252
| -3% | -$326K |
|
1223
Under Armour Class C
UA
$2.2B
| $10.1M | ﹤0.01% |
1,255,966
-7,287,730
| -85% | -$105M |
|
1224
BorgWarner
BWA
$14B
| $10.1M | ﹤0.01% |
470,267
+37,845
| +9% | +$1.09M |
|
1225
Conduent
CNDT
$241M
| $9.98M | ﹤0.01% |
4,072,349
-112,185
| -3% | -$445K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.